- Home
- EVR vs ASND Comparison
EVR vs ASND Comparison
Compare EVR & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVR
- ASND
- Stock Information
- Founded
- EVR 1995
- ASND 2006
- Country
- EVR United States
- ASND Denmark
- Employees
- EVR N/A
- ASND 1017
- Industry
- EVR Investment Managers
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- EVR Finance
- ASND Health Care
- Exchange
- EVR Nasdaq
- ASND Nasdaq
- Market Cap
- EVR 12.5B
- ASND 12.2B
- IPO Year
- EVR 2006
- ASND 2015
- Fundamental
- Price
- EVR $296.88
- ASND $208.32
- Analyst Decision
- EVR Buy
- ASND Strong Buy
- Analyst Count
- EVR 9
- ASND 17
- Target Price
- EVR $320.11
- ASND $245.76
- AVG Volume (30 Days)
- EVR 456.8K
- ASND 407.0K
- Earning Date
- EVR 10-29-2025
- ASND 11-04-2025
- Dividend Yield
- EVR 1.13%
- ASND N/A
- EPS Growth
- EVR 61.35
- ASND N/A
- EPS
- EVR 12.55
- ASND N/A
- Revenue
- EVR $3,543,533,000.00
- ASND $576,332,355.00
- Revenue This Year
- EVR $24.72
- ASND $104.98
- Revenue Next Year
- EVR $17.06
- ASND $79.91
- P/E Ratio
- EVR $23.76
- ASND N/A
- Revenue Growth
- EVR 27.05
- ASND 54.50
- 52 Week Low
- EVR $148.63
- ASND $118.03
- 52 Week High
- EVR $364.42
- ASND $216.45
- Technical
- Relative Strength Index (RSI)
- EVR 38.21
- ASND 57.09
- Support Level
- EVR $311.88
- ASND $195.03
- Resistance Level
- EVR $332.49
- ASND $208.39
- Average True Range (ATR)
- EVR 10.79
- ASND 8.24
- MACD
- EVR -2.30
- ASND -0.46
- Stochastic Oscillator
- EVR 19.96
- ASND 78.36
About EVR Evercore Inc.
Evercore is a leading independent investment banking advisory firm that generates most of its business by offering services to facilitate mergers and acquisitions, restructurings, and capital raising, in addition to equities trading and investment management. Founded in 1995, it has built a reputation for advising on some of the world's largest and most complex transactions. The firm operates globally with a strong presence in the US and Europe, serving corporations, financial sponsors, and government clients. Its business model emphasizes high-touch, conflict-free advice rather than balance sheet lending, allowing it to compete with larger bulge-bracket banks.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.